Chinese Journal of Antituberculosis ›› 2023, Vol. 45 ›› Issue (8): 728-733.doi: 10.19982/j.issn.1000-6621.20230129
• Original Articles • Previous Articles Next Articles
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong()
Received:
2023-04-24
Online:
2023-08-10
Published:
2023-08-09
Contact:
Huang Hairong
E-mail:huanghairong@tb123.org
Supported by:
CLC Number:
Ren Ruyan, Xue Yi, Liang Qian, Huang Hairong. The mechanisms identification of the susceptibility discrepancy to isoniazid among clinical isolates of Mycobacterium kansasii[J]. Chinese Journal of Antituberculosis, 2023, 45(8): 728-733. doi: 10.19982/j.issn.1000-6621.20230129
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.19982/j.issn.1000-6621.20230129
[1] |
Adjemian J, Frankland TB, Daida YG, et al. Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA. Emerg Infect Dis, 2017, 23(3): 439-447. doi:10.3201/eid2303.161827.
doi: 10.3201/eid2303.161827 pmid: 28221128 |
[2] |
Zhou L, Xu D, Liu H, et al. Trends in the Prevalence and Antibiotic Resistance of Non-tuberculous Mycobacteria in Mainland China, 2000—2019: Systematic Review and Meta-Analysis. Front Public Health, 2020, 8: 295. doi:10.3389/fpubh.2020.00295.
doi: 10.3389/fpubh.2020.00295 pmid: 32850570 |
[3] |
滕田璐, 尚园园, 黄海荣, 等. 四种常见外排泵抑制剂对克拉霉素抗脓肿分枝杆菌体外最低抑菌浓度的影响. 中华结核和呼吸杂志, 2022, 45(5): 468-474. doi:10.3760/cma.j.cn112147-20210923-00669.
doi: 10.3760/cma.j.cn112147-20210923-00669 |
[4] |
Bakuła Z, Modrzejewska M, Pennings L, et al. Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii. Antimicrob Agents Chemother, 2018, 62(4): e01788-17. doi:10.1128/AAC.01788-17.
doi: 10.1128/AAC.01788-17 |
[5] |
Vilchèze C, Jacobs WR Jr. The Isoniazid Paradigm of Killing, Resistance, and Persistence in Mycobacterium tuberculosis. J Mol Biol, 2019, 431(18): 3450-3461. doi:10.1016/j.jmb.2019.02.016.
doi: 10.1016/j.jmb.2019.02.016 URL |
[6] |
Aeschlimann JR, Dresser LD, Kaatz GW, et al. Effects of NorA inhibitors on in vitro antibacterial activities and postantibiotic effects of levofloxacin, ciprofloxacin, and norfloxacin in genetically related strains of Staphylococcus aureus. Antimicrob Agents Chemother, 1999, 43(2):335-340. doi:10.1128/AAC.43.2.335.
doi: 10.1128/AAC.43.2.335 pmid: 9925528 |
[7] | Singh M, Jadaun GP, Ramdas, et al. Effect of efflux pump inhibitors on drug susceptibility of ofloxacin resistant Mycobacterium tuberculosis isolates. Indian J Med Res, 2011, 133(5): 535-540. |
[8] |
Ramón-García S, Martín C, Thompson CJ, et al. Role of the Mycobacterium tuberculosis P 55 efflux pump in intrinsic drug resistance, oxidative stress responses, and growth. Antimicrob Agents Chemother, 2009, 53(9): 3675-3682. doi:10.1128/AAC.00550-09.
doi: 10.1128/AAC.00550-09 pmid: 19564371 |
[9] |
Kaestner KH, Randall SK, Sze H. N,N'-dicyclohexylcarbodiimide-binding proteolipid of the vacuolar H+-ATPase from oat roots. J Biol Chem, 1988, 263(3): 1282-1287.
pmid: 2891708 |
[10] |
Brown MH, Paulsen IT, Skurray RA. The multidrug efflux protein NorM is a prototype of a new family of transporters. Mol Microbiol, 1999, 31(1): 394-395. doi:10.1046/j.1365-2958.1999.01162.x.
doi: 10.1046/j.1365-2958.1999.01162.x pmid: 9987140 |
[11] |
Poelarends GJ, Mazurkiewicz P, Konings WN. Multidrug transporters and antibiotic resistance in Lactococcus lactis. Biochim Biophys Acta, 2002, 1555(1-3): 1-7. doi:10.1016/s0005-2728(02)00246-3.
doi: 10.1016/s0005-2728(02)00246-3 pmid: 12206883 |
[12] |
Ghajavand H, Kargarpour Kamakoli M, Khanipour S, et al. Scrutinizing the drug resistance mechanism of multi- and extensively-drug resistant Mycobacterium tuberculosis: mutations versus efflux pumps. Antimicrob Resist Infect Control, 2019, 8: 70. doi:10.1186/s13756-019-0516-4.
doi: 10.1186/s13756-019-0516-4 |
[13] |
Machado D, Perdigão J, Portugal I, et al. Efflux Activity Differentially Modulates the Levels of Isoniazid and Rifampicin Resistance among Multidrug Resistant and Monoresistant Mycobacterium tuberculosis Strains. Antibiotics (Basel), 2018, 7(1): 18. doi:10.3390/antibiotics7010018.
doi: 10.3390/antibiotics7010018 |
[14] |
Just I, Selzer J, Wilm M, et al. Glucosylation of Rho proteins by Clostridium difficile toxin B. Nature, 1995, 375(6531): 500-503. doi:10.1038/375500a0.
doi: 10.1038/375500a0 |
[15] |
Rodrigues L, Machado D, Couto I, et al. Contribution of efflux activity to isoniazid resistance in the Mycobacterium tuberculosis complex. Infect Genet Evol, 2012, 12(4): 695-700. doi:10.1016/j.meegid.2011.08.009.
doi: 10.1016/j.meegid.2011.08.009 pmid: 21871582 |
[16] |
Ng VH, Cox JS, Sousa AO, et al. Role of KatG catalase-peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst. Mol Microbiol, 2004, 52(5): 1291-1302. doi:10.1111/j.1365-2958.2004.04078.x.
doi: 10.1111/j.1365-2958.2004.04078.x pmid: 15165233 |
[17] |
Guo Y, Cao Y, Liu H, et al. Clinical and Microbiological Characteristics of Mycobacterium kansasii Pulmonary Infections in China. Microbiol Spectr, 2022, 10(1): e0147521. doi:10.1128/spectrum.01475-21.
doi: 10.1128/spectrum.01475-21 |
[18] |
DeStefano MS, Shoen CM, Cynamon MH. Therapy for Mycobacterium kansasii Infection: Beyond 2018. Front Microbiol, 2018, 9: 2271. doi:10.3389/fmicb.2018.02271.
doi: 10.3389/fmicb.2018.02271 pmid: 30319580 |
[19] |
Reingewertz TH, Meyer T, McIntosh F, et al. Differential Sensitivity of Mycobacteria to Isoniazid Is Related to Differences in KatG-Mediated Enzymatic Activation of the Drug. Antimicrob Agents Chemother, 2020, 64(2): e01899-19. doi:10.1128/AAC.01899-19.
doi: 10.1128/AAC.01899-19 |
[20] |
莫凌, 张文宏, 王骥, 等. KatG基因点突变与结核分枝杆菌异烟肼耐药相关性研究. 中华传染病杂志, 2004, 22(2): 94-97. doi:10.3760/j.issn:1000-6680.2004.02.006.
doi: 10.3760/j.issn:1000-6680.2004.02.006 |
[21] | 张宗德, 马玙, 程绍基, 等. 异烟肼耐药与结核分支杆菌katG基因突变的研究. 中华结核和呼吸杂志, 1996, 19(6):346-349. |
[22] | 张宗德, 马玙, 贾红艳. 结核分支杆菌katG基因第463位密码子突变与异烟肼耐药的研究. 中华结核和呼吸杂志, 1999, 22(3):168. |
[1] | TIAN Li, ZHOU Wei, HUANG Xing, WU Xian-wei, ZHANG Hui-yong, LU Zhen-hui, ZHANG Shao-yan. Analysis of gene mutation characteristics of isoniazid-resistant Mycobacterium tuberculosis in China [J]. Chinese Journal of Antituberculosis, 2022, 44(4): 354-361. |
[2] | SHU Wei, GE Qi-ping, HUANG Xue-rui, MA Li-ping, JI Bin-ying, CHEN Yu-hui, CHEN Xiao-you, JIANG Guang-lu, XIE Li, LI Bo, CHEN Sheng-yu, CHEN Sen-lin, YAN Jun-ping, SHI Lian, CHEN Ling, LI You-lun, XI Xiu-e, LIU Qian-ying, YAN Xing-lu, WANG Fei, WANG Fu-rong, WU Xiang, ZHANG Peng, LENG Xue-yan, CAO Wen-li, ZHANG Hai-qing, CUI Hong-zhe, YANG Cheng-qing, WU Chao, LI Juan, LI Hua, SUN Yu-xian, ZHANG Li-jie, XIE Shi-heng, NING Yu-jia, TIAN Xi-zhong, DU Jian, LI Liang, GAO Wei-wei. Analysis of treatment outcomes of retreated pulmonary tuberculosis patients with isoniazid-resistance and rifampin-resistance [J]. Chinese Journal of Antituberculosis, 2021, 43(4): 322-327. |
[3] | YANG Qing-luan, LIU Qi-hui, LIN Miao-yao, XU Yu-zhen, LIU Xue-feng, HE Zhang-yu-fan, HUANG Xi-tian, HAO Bin, SHAO Ling-yun, ZHANG Wen-hong, RUAN Qiao-ling. A study of pharmacokinetic of rifapentine combined with isoniazid in the preventive treatment of tuberculosis in silicotic patients [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 228-232. |
[4] | WANG Xi-jiang, TAN Yun-hong, HE Wen-cong, OU Xi-chao, LIU Dong-xin, ZHAO Yan-lin. The correlation between rifampicin and isoniazid resistance-related gene mutations and resistance level in Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2021, 43(3): 248-254. |
[5] | YUAN Yuan, MA Jia-ye, LIU Xu-hui, XIA Lu, LIU Ping, JIA Xiao-long, LU Shui-hua. Pharmacokinetics and safety of high-dose isoniazid and rifapentine in healthy han population: A bio-equivalence trial [J]. Chinese Journal of Antituberculosis, 2021, 43(12): 1314-1321. |
[6] | Beijing Chest Hospital,Capital Medical University,Editorial Board of Chinese Journal of Antituberculosis . Expert consensus on polymorphism detection of N-acetyltransferase-2 encoding gene and appropriate isoniazid dosing for tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2021, 43(11): 1107-1112. |
[7] | ZHAO Jiao-jie,FU Lei,WANG Bin,ZHANG Lei,HU Ming-hao,LU Yu. Establishment and application of pharmacodynamics and pharmacokinetics model in vitro [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 372-379. |
[8] | SONG Yan-hua,GAO Meng-qiu,LI Qi. Research progress on the mechanism of drug resistance of Mycobacterium tuberculosis to ethionamide/pthionamide and ethionamide boosters [J]. Chinese Journal of Antituberculosis, 2020, 42(2): 173-177. |
[9] | Maimaitiaili ·Aihemuti, HUANG Qiao-ling, Guerseman ·Abula, Renati ·Ailaiti. Analysis of drug-resistance to rifampin and isoniazid in 1307 patients with pulmonary tuberculosis in Kashi, Xinjiang [J]. Chinese Journal of Antituberculosis, 2020, 42(11): 1209-1213. |
[10] | ZHANG Man-e,HUANG Wen-bin,LU Zhi-hua,ZHANG Hong-bin. Study on resistance to rifampicin and isoniazid in 411 cases of pulmonary tuberculosis in Longyan City, Fujian Province [J]. Chinese Journal of Antituberculosis, 2020, 42(1): 54-59. |
[11] | Yuan LIU,Jun ZHOU,Xiao-li CUI,Jia-yuan LEI,Li-yun DANG. Evaluation on the performance of gene chip and linear probe technique in detecting MTB drug resistance in sputum samples from smear-positive pulmonary tuberculosis patients [J]. Chinese Journal of Antituberculosis, 2019, 41(7): 738-742. |
[12] | Xue-juan BAI,Yin-ping LIU,Jun-xian ZHANG,Jie WANG,Xue-qiong WU. Direct detection of rifampicin and isoniazid resistance-associated genes in clinical specimens from the patients with tuberculosis using gene chip [J]. Chinese Journal of Antituberculosis, 2019, 41(2): 138-144. |
[13] | JIANG Li-na,MU Cheng,SUN Rui,WANG Zhi-rui,DAI Wen-xi,WANG Chun-hua. Detection value of the second-generation linear probe technique for drug resistance in Mycobacterium tuberculosis culture-positive isolates [J]. Chinese Journal of Antituberculosis, 2019, 41(11): 1184-1190. |
[14] | Hui-na WU,Fu-sheng SUN,Qing-wen LIU,Zhong-lu RONG,Ji-dong ZHANG,Yang GAO,Yong-fu LI,Fei CHANG. The value of fluorescent PCR probe melting curve analysis in detection of Mycobacterium tuberculosis complex for rifa-mpicin and isoniazid resistance [J]. Chinese Journal of Antituberculosis, 2019, 41(1): 74-79. |
[15] | Yan LIU,Mulati Gulibike·,Abulitifu Maliyamu·,Xing YI,Jun-lian LI,Yong-huan SHI,Tian-jian LIU. Results analysis on detection of drug resistance gene of Mycobacterium tuberculosis by using fluorescence PCR melting curve method [J]. Chinese Journal of Antituberculosis, 2018, 40(9): 959-963. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||